Published in Trans Am Assoc Genitourin Surg on January 01, 1970
Current concepts. Pheochromocytoma: diagnosis, localization and management. N Engl J Med (1984) 2.09
Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration. Ann Intern Med (1971) 2.05
Primum non nocere. JAMA (1977) 1.79
Choice of initial therapy for hypertension. JAMA (1996) 1.51
Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med (1979) 1.49
Isolated systolic hypertension in the elderly. Some controversial issues. JAMA (1982) 1.39
Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29
Prognostic importance of ophthalmoscopic findings in essential hypertension. JAMA (1966) 1.21
Evaluation of the hypertensive patient. Chest (1973) 1.21
Experience with extra-adrenal pheochromocytoma. J Urol (1989) 1.20
Renal trauma and hypertension. Am J Cardiol (1971) 1.19
Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Pharm Res (2000) 1.19
Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med (1981) 1.18
Mortality and morbidity in pretransplant bilateral nephrectomy: analysis of 305 cases. Urology (1978) 1.13
Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion. J Clin Pharmacol (2000) 1.12
Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases. Arch Intern Med (1970) 1.12
The changing clinical spectrum of primary aldosteronism. Am J Med (1983) 1.11
The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J Urol (1977) 1.11
Localization of pheochromocytoma by computed tomography. N Engl J Med (1978) 1.09
Essential hypertension. A twenty-year follow-up study. Circulation (1966) 1.09
Revascularization for preservation of renal function in patients with atherosclerotic renovascular disease. J Urol (1983) 1.08
Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity. J Biol Chem (1992) 1.07
D-penicillamine therapy in cystinuria. J Urol (1966) 1.07
Four years' clinical experience with 138 kidney transplants. J Urol (1968) 1.06
Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59. Blood (1990) 1.05
Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure. Br Heart J (1984) 1.04
Migration of a Kirschner wire from the clavicle into the pulmonary artery. Am J Cardiol (1965) 1.01
Trends in surgical revascularization for renal artery disease. Ten years' experience. JAMA (1987) 1.01
Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders. Urology (1978) 1.01
The Cleveland Clinic experience with adrenal cortical carcinoma. J Urol (1989) 1.00
Left renal venous hypertension "nutcracker" syndrome. Managed by direct renocaval reimplantation. Urology (1982) 1.00
The role of renal autotransplantation in complex urological reconstruction. J Urol (1990) 0.97
Antihypertensive drugs: clinical pharmacology and therapeutic use. Drugs (1977) 0.97
The atrophic kidney: its role in hypertension. Mayo Clin Proc (1965) 0.97
Drug combinations as rational antihypertensive therapy. Arch Intern Med (1974) 0.96
Idiopathic retroperitoneal fibrosis: diagnostic enigma: report of a case simulating diabetes insipidus and a review of the literature. J Urol (1966) 0.96
Pheochromocytoma. Endocrinol Metab Clin North Am (1993) 0.95
Experimental and clinical hepatorenal bypass as a means of revascularization of the right renal artery. Surg Gynecol Obstet (1979) 0.94
Diminished operative morbidity and mortality in renal revascularization. JAMA (1981) 0.93
Dietary salt and essential hypertension. Am J Cardiol (1972) 0.93
Renal splanchnic steal and hypertension. Radiology (1972) 0.92
Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med (1990) 0.92
A guide to the practical use of diuretics. JAMA (1976) 0.91
Surgery for renal cell carcinoma extending into the inferior vena cava. J Urol (1978) 0.91
Retroperitoneal malignancy masquerading as benign retroperitoneal fibrosis. J Urol (1970) 0.91
Urinary cytology and the clinical diagnosis of urinary tract malignancy: a clinicopathologic study of 1,400 patients. J Urol (1971) 0.91
Three years' clinical experience with cadaver kidney transplantation. Transplantation (1967) 0.91
Resistant hypertension: diagnosis and management. Ann Intern Med (1978) 0.91
CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs. J Pharm Sci (1999) 0.90
Renal-splanchnic steal. Report of a case. Cleve Clin Q (1967) 0.90
Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol (1984) 0.90
Correlation of angiography and natural history in evaluation of patients with renovascular hypertension. J Urol (1970) 0.89
Pheochromocytoma: a clinical and experimental overview. Curr Probl Cancer (1985) 0.89
Splenorenal bypass in the treatment of stenosis of the renal artery. Surg Gynecol Obstet (1977) 0.89
Managing hypertension: the postgraduate medicine lecture. Postgrad Med (1977) 0.89
Hypertension and stroke. J Am Coll Cardiol (1983) 0.89
The use and abuse of antihypertensive drugs in the aged. Geriatrics (1967) 0.89
Redistribution of cardiac output to the kidneys during oral nadolol administration. N Engl J Med (1982) 0.89
Techniques of cutaneous ureterostomy and results in 51 patients. J Urol (1970) 0.88
Electrocardiogram in evaluation of resistance to antihypertensive therapy. Arch Intern Med (1977) 0.88
Renal vascular hypertension; diagnosis and treatment. Prog Cardiovasc Dis (1965) 0.88
Surgical treatment of renal artery aneurysms. Br J Urol (1983) 0.88
Renal revascularization in patients with total occlusion of the renal artery. J Urol (1980) 0.88
Lymphocytes associated with renal transplantation. Report of 15 cases and review of the literature. Am J Med (1974) 0.87
Long-term results with renal autotransplantation for ureteral replacement. J Urol (1986) 0.87
Stomal complications of intestinal conduit urinary diversion. Cleve Clin J Med (1989) 0.87
Ruptured human renal allograft. Pathogenesis and management. Urology (1978) 0.87
Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes. J Pharm Sci (1996) 0.87
Partial cystectomy in the treatment of primary and secondary carcinoma of the bladder. J Urol (1976) 0.86
Retransplantation after failure of first renal homografts. Studies in 19 patients. JAMA (1967) 0.86
Diagnosis and management of pheochromocytoma. Cardiology (1985) 0.86
Varicocele in infertility: incidence and results of surgical therapy. J Urol (1974) 0.86
Hypertensive encephalopathy: Mechanisms, clinical features, and treatment. Prog Cardiovasc Dis (1974) 0.86
Blood pressure regulation in pheochromocytoma. Hypertension (1982) 0.86
Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties. J Med Chem (1997) 0.86
Lymphadenectomy in renal adenocarcinoma. J Urol (1982) 0.86
Experimental bladder substitution using a biodegradable graft of natural tissue. J Biomed Mater Res (1978) 0.86
Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds. Pharm Res (1998) 0.85